SAFETY ANALYSIS OF PATIENTS WITH A MEDICAL HISTORY OF RESPIRATORY DISORDERS TREATED WITH COPANLISIB FROM THE CHRONOS‐1 STUDY IN RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA. (12th June 2019) - Zinzani, P.L.; Santoro, A.; Leppä, S.; Demeter, J.; Follows, G.A.; Lenz, G.; Kim, W.S.; Mollica, L.; Nagler, A.; Phipps Diong, C.; Provencio, M.; Magagnoli, M.; et al.